About Takeda Pharmaceuticals
Takeda Pharmaceuticals is a company based in Dublin (Ireland) founded in 1986 was acquired by Takeda in May 2018. It operates as a Direct-to-Consumer (D2C), and Professional Services. Takeda Pharmaceuticals has raised $17 million across 2 funding rounds from investors including Takeda Pharmaceuticals. Takeda Pharmaceuticals has completed 16 acquisitions, including Advanced BioHealing, Baxalta and Bikam Pharmaceuticals. Takeda Pharmaceuticals offers products and services including Oveporexton (TAK-861), Plasma-Derived Therapies, and Vaccines. Takeda Pharmaceuticals operates in a competitive market with competitors including Vir Biotechnology, Vaxcyte, Cidara Therapeutics, Freeline and Valneva, among others.
- Headquarter Dublin, Ireland
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Takeda Pharmaceutical Company Limited
- Date of Incorporation 22 Sep, 2017
- Jurisdiction Gurgaon, Haryana, India
-
Annual Revenue
$1.68 M (USD)24.41as on Mar 31, 2022
-
Net Profit
$5.02 K (USD)4.94as on Mar 31, 2022
-
EBITDA
$-375.83 K (USD)-158.6as on Mar 31, 2022
-
Total Equity Funding
$17 M (USD)
in 2 rounds
-
Latest Funding Round
$15 M (USD), Series B
Oct 30, 2013
- Investors
-
Employee Count
Employee Count
-
Investments & Acquisitions
Advanced BioHealing
& 15 more
-
Acquired by
Takeda
(May 12, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Takeda Pharmaceuticals
Takeda Pharmaceuticals offers a comprehensive portfolio of products and services, including Oveporexton (TAK-861), Plasma-Derived Therapies, and Vaccines. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Developed for treating Narcolepsy Type 1 patients.
Innovated for rare and complex chronic diseases.
Created to address global infectious disease needs.
Unlock access to complete
Unlock access to complete
Software Development Team
330 people
Leadership Team
187 people
Data Analysis and Operations Team
65 people
Operations Team
60 people
Head Team
47 people
Legal and Compliance
43 people
Human Resources and Administration
42 people
Product Management Team
40 people
Unlock access to complete
Funding Insights of Takeda Pharmaceuticals
Takeda Pharmaceuticals has successfully raised a total of $17M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $15 million completed in October 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $15.0M
-
First Round
First Round
(18 Jul 2011)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2013 | Amount | Series B - Takeda Pharmaceuticals | Valuation |
investors |
|
| Jul, 2011 | Amount | Series A - Takeda Pharmaceuticals | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Takeda Pharmaceuticals
Takeda Pharmaceuticals has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Takeda Pharmaceuticals. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Takeda Pharmaceuticals is engaged in developing innovative medicines globally.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Takeda Pharmaceuticals
Takeda Pharmaceuticals has strategically engaged in corporate development activities, having acquired 16 companies. Notable acquisitions include Advanced BioHealing, Baxalta and Bikam Pharmaceuticals. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Developer of therapies for orphan diseases and other disease conditions
|
2015 | ||||
|
Passionately pursuing better treatments for adults and children with rare liver diseases.
|
2011 | ||||
|
Recombinant collagen technology is developed for chronic wound healing treatments.
|
2010 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Takeda Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Takeda Pharmaceuticals Comparisons
Competitors of Takeda Pharmaceuticals
Takeda Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Vir Biotechnology, Vaxcyte, Cidara Therapeutics, Freeline and Valneva, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of therapeutics for the treatment of infectious diseases
|
|
| domain | founded_year | HQ Location |
Vaccines for infectious diseases are developed using cell-free protein synthesis.
|
|
| domain | founded_year | HQ Location |
Novel anti-infectives for bacterial and fungal infections are developed.
|
|
| domain | founded_year | HQ Location |
Gene therapy platform is developed for chronic disease treatments.
|
|
| domain | founded_year | HQ Location |
Prophylactic vaccines for infectious diseases are developed and advanced.
|
|
| domain | founded_year | HQ Location |
Vaccines and immuno-biological drugs for infectious diseases are manufactured.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Takeda Pharmaceuticals
Frequently Asked Questions about Takeda Pharmaceuticals
When was Takeda Pharmaceuticals founded?
Takeda Pharmaceuticals was founded in 1986 and raised its 1st funding round 25 years after it was founded.
Where is Takeda Pharmaceuticals located?
Takeda Pharmaceuticals is headquartered in Dublin, Ireland.
Is Takeda Pharmaceuticals a funded company?
Takeda Pharmaceuticals is a funded company, having raised a total of $17M across 2 funding rounds to date. The company's 1st funding round was a Series A of $2M, raised on Jul 18, 2011.
What is the annual revenue of Takeda Pharmaceuticals?
Annual revenue of Takeda Pharmaceuticals is $1.68M as on Mar 31, 2022.
What does Takeda Pharmaceuticals do?
Takeda Pharmaceuticals is involved in the research, development, and manufacturing of innovative medicines. The company focuses on areas such as gastrointestinal and inflammatory diseases, rare diseases, plasma-derived therapies, oncology, neuroscience, and vaccines. Solutions are provided to address unmet medical needs across various sectors, aiming to improve health outcomes and transform lives worldwide. Operations span multiple countries, ensuring a broad impact on global health systems.
Who are the top competitors of Takeda Pharmaceuticals?
Takeda Pharmaceuticals's top competitors include Vaxcyte, Serum Institute of India and Biological E.
What products or services does Takeda Pharmaceuticals offer?
Takeda Pharmaceuticals offers Oveporexton (TAK-861), Plasma-Derived Therapies, and Vaccines.
How many acquisitions has Takeda Pharmaceuticals made?
Takeda Pharmaceuticals has made 16 acquisitions, including Advanced BioHealing, Baxalta, and Bikam Pharmaceuticals.
Who are Takeda Pharmaceuticals's investors?
Takeda Pharmaceuticals has 1 investor. Key investors include Takeda Pharmaceuticals.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.